NF-kB p65, Human, mAb 14H2

Catalog #: HM2345
Quantity: 100 µg

Original supplier of innate immunity products since 1994.

Our commitment to quality: Read more!

Contact our support team for more product information.

Can't find your application for a product? Request a sample!

Mouse monoclonal antibody 14H2 recognizes human Nuclear factor- kB (NF-kB )p65, also called RelA-p65. NF-kB is considered to be one of the main transcription factors driving the expression of genes of inflammatory and immune responses, regulated by a divers panel of modifications to exerts it divers function. Other family members in mammals are RelB, c-Rel, NF-kB1 and NF-kB2, the latter two are processed in respectively p105/p50 and p100/p52. NF-kB functions as a dimer and they all share a Rel homology domain, responsible for DNA binding and dimerization. The activity of NF-kB is regulated by interaction with a family of inhibitory IkB proteins. The different NF-kB complexes have their own individual IkB proteins. In general NF-kB is present as IkB -complex in the cytoplasm. When the inflammatory response is triggered by eg proinflammatory cytokines or LPS, this leads to phosphorylation of IkB via IKK complex (IKKα, IKKβ and NEMO) leading to release of NF-kB from the complex. Subsequently, NF-kB enters the nucleus where it activates gene expression. NF-kB activation consist out of two activation pathways. The canonical pathway is the most common one. In the canonical pathway, IκBα is phosphorylated in an IKKβ- and NEMO-dependent manner, which results in the nuclear translocation of mostly p65-containing heterodimers. In contrast, the non-canonical pathway involves IKKα-mediated phosphorylation of p100 associated with RelB, which leads to partial processing of p100 and the generation of transcriptionally active p52-RelB complexes. Besides inflammation, auto-immune and metabolic diseases, NF-kB is involved in tumor development. Related inflammatory diseases are IBD, rheumatoid arthritis, SLE, diabetis, celiac disease, multiple sclerosis and Parkinson’s disease.


Catalog number HM2345
Product type Monoclonal antibodies
Quantity 100 µg
Formulation 0.1 ml (1 mg/ml) 0.2 μm filtered antibody solution in PBS, containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Immunogen Synthetic NF-kB p65 peptide
Isotype Mouse IgG1
Species Human
Cross reactivity Mouse - Yes, Rat - Yes
Alias RELA; NFKB3; Transcription factor p65; Nuclear factor NF-kappa-B p65 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3
Storage and stability Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
Precautions For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result from the use or derivation of this product.
Disease Autoimmunity, Infectious diseases
  • Application:
    F, IP, P, W
  • Application Notes:
    W: A non-reduced and reduced sample treatment and SDS-Page was used. The band size is 65 kDa.
  • Use:
    Dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.